Advertisement

SemBioSys stock plunges on word of TSX delisting, layoffs and possible windup

CALGARY – SemBioSys Genetics Inc. (TSX:SBS) stock plunged 70 per cent on Wednesday after it announced a voluntary delisting from the Toronto Stock Exchange and said the company may be wound up if it can’t find a buyer or financial backer.

The development-stage company, which has proprietary technology for creating high-value proteins, said Wednesday it has laid off most of its staff and contractors and it’s looking for a strategic deal or a windup of the company.

Get expert insights, Q&A on markets, housing, inflation, and personal finance information delivered to you every Saturday.

Get weekly money news

Get expert insights, Q&A on markets, housing, inflation, and personal finance information delivered to you every Saturday.
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy.

SemBioSys signed a strategic partnership with Tianjin Tasly Pharmaceuticals Co. Ltd. and Tasly Pharmaceuticals Inc. in October but SemBioSys said Wednesday there hasn’t been any financial benefit to it since then.

The Calgary-based company says it hasn’t transferred any intellectual property to the joint venture to date.

Its shares closed Tuesday at 6.5 cents, giving SemBioSys a total market value of less than $3.4 million at that time. But the stock plunged when the Toronto Stock Exchange, cutting the market value by about 70 per cent.

Story continues below advertisement

SemBioSys shares were down 4.5 cents to two cents in early trading.

Sponsored content

AdChoices